PseudoPatient

NSH CyberKnife Cancer Center at the Neuro Spinal Hospital in Dubai has conducted its first simulated therapy for multiple brain cavernomas using PseudoPatient, RTsafe’s patient-specific quality assurance process. This represents the first application of PseudoPatient in the Gulf region. The hospital is said to be the first in the UAE to use the CyberKnife system […]

Spain’s Fundación Instituto Valenciano de Oncología (IVO) has conducted its first simulated therapy for brain metastases using RTsafe’s PseudoPatient. This patient-specific quality assurance process comprises an anatomically faithful model of each patient’s head aligned to dosimetric evaluation services. The technology enables medical physicists and clinicians to verify the entire treatment process before the patient is […]